Anchor Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Anchor Capital Advisors's LLY Position: Q3 2026 in Review
Anchor Capital Advisors increased its Eli Lilly (LLY) stake by 3.5% in Q3 2026, buying an estimated $29.5K and bringing the position to 746 shares worth $863K. The position accounts for 0.03% of the portfolio, ranked #179.
Anchor Capital Advisors first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $865K in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Anchor Capital Advisors held 746 shares of Eli Lilly worth $863K as of Q3 2026.
- Anchor Capital Advisors bought 25 Eli Lilly shares in Q3 2026, an estimated $29.5K.
- Eli Lilly made up 0.03% of Anchor Capital Advisors's portfolio in Q3 2026, its #179 holding.
- Anchor Capital Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
- Anchor Capital Advisors's Eli Lilly position peaked at $865K in Q2 2026.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Anchor Capital Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.